Amanote Research

Amanote Research

    RegisterSign In

US Food and Drug Administration Disruption of Generic Drug Market Increases Hospital Costs

Anesthesia and Analgesia - United States
doi 10.1213/ane.0000000000003589
Full Text
Open PDF
Abstract

Available in full text

Categories
AnesthesiologyPain Medicine
Date

December 1, 2018

Authors
Philip J. AlmeterJonathan A. LabuhnPeter E. MorrisEugene A. Hessel
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration

JAMA network open
Medicine
2019English

Food and Drug Administration

2003English

A Randomized Trial Testing US Food and Drug Administration “Breakthrough” Language

JAMA Internal Medicine
Internal Medicine
2015English

Transparency and Dermatologic Device Approval by the US Food and Drug Administration

JAMA Dermatology
DermatologyMedicine
2018English

US Food and Drug Administration Considers Comments on Proposed Nicotine Product Regulations

Cancer
Cancer ResearchOncology
2018English

Have Thoracic Endografting Outcomes Improved Since US Food and Drug Administration Approval?

Annals of Thoracic Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2011English

From the Food and Drug Administration

JAMA - Journal of the American Medical Association
Medicine
1986English

From the Food and Drug Administration

JAMA - Journal of the American Medical Association
Medicine
1993English

From the Food and Drug Administration

JAMA - Journal of the American Medical Association
Medicine
1991English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy